Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,867 | 358 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $864.25 | 53 | $0 (2024) |
| Novo Nordisk Inc | $647.88 | 46 | $0 (2023) |
| Lilly USA, LLC | $509.18 | 31 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $453.20 | 22 | $0 (2024) |
| PFIZER INC. | $413.85 | 33 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $353.23 | 24 | $0 (2024) |
| Esperion Therapeutics, Inc. | $293.19 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $259.91 | 16 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $229.55 | 16 | $0 (2024) |
| Abbott Laboratories | $215.24 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,322 | 75 | AstraZeneca Pharmaceuticals LP ($261.82) |
| 2023 | $1,474 | 96 | Lilly USA, LLC ($230.86) |
| 2022 | $1,433 | 88 | Esperion Therapeutics, Inc. ($181.50) |
| 2021 | $1,638 | 99 | AbbVie Inc. ($469.28) |
All Payment Transactions
358 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Respiratory | ||||||
| 11/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $10.19 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/30/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.04 | General |
| 10/29/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/07/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Bone Health | ||||||
| 10/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: DIABETES | ||||||
| 09/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Cardio-renal | ||||||
| 09/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Biological | ||||||
| 09/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: DIABETES | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Gastroenterology | ||||||
| 08/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.98 | General |
| 08/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/23/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Cardio-renal | ||||||
| 08/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: PSYCHIATRY | ||||||
| 08/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 546 | 813 | $144,821 | $47,817 |
| 2022 | 13 | 627 | 919 | $151,333 | $56,573 |
| 2021 | 14 | 637 | 947 | $144,759 | $56,622 |
| 2020 | 11 | 660 | 917 | $125,542 | $42,189 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 137 | 333 | $80,919 | $22,133 | 27.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 120 | 120 | $29,760 | $12,464 | 41.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 82 | $14,104 | $3,758 | 26.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $6,890 | $3,663 | 53.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 36 | 36 | $5,292 | $2,518 | 47.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 37 | 37 | $2,146 | $1,058 | 49.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 66 | 110 | $3,410 | $1,019 | 29.9% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 16 | 18 | $1,116 | $570.60 | 51.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $728.00 | $371.80 | 51.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 24 | 24 | $240.00 | $201.60 | 84.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 21 | 27 | $216.00 | $59.40 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 137 | 331 | $70,774 | $21,585 | 30.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 144 | 144 | $33,334 | $14,995 | 45.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 19 | 19 | $9,558 | $5,291 | 55.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 72 | 94 | $13,928 | $4,628 | 33.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 38 | 40 | $5,544 | $2,735 | 49.3% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 16 | 18 | $6,192 | $2,386 | 38.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 63 | 119 | $3,689 | $1,134 | 30.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 39 | 41 | $2,242 | $1,106 | 49.3% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 30 | 30 | $2,400 | $1,069 | 44.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 24 | 24 | $1,092 | $650.16 | 59.5% |
| 0051A | Adm sarscv2 30mcg trs-sucr 1 | Office | 2022 | 13 | 13 | $1,040 | $467.74 | 45.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 14 | 15 | $1,320 | $456.04 | 34.5% |
| 81003 | Automated urinalysis test | Office | 2022 | 18 | 31 | $220.00 | $69.13 | 31.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 152 | 365 | $73,789 | $26,036 | 35.3% |
About Larry Hubbs, ARNP
Larry Hubbs, ARNP is a Family healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316032519.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Larry Hubbs, ARNP has received a total of $5,867 in payments from pharmaceutical and medical device companies, with $1,322 received in 2024. These payments were reported across 358 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($5,867).
As a Medicare-enrolled provider, Hubbs has provided services to 2,470 Medicare beneficiaries, totaling 3,596 services with total Medicare billing of $203,201. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Lexington, KY
- Active Since 10/04/2006
- Last Updated 10/02/2024
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1316032519
Products in Payments
- VRAYLAR (Drug) $415.58
- MOUNJARO (Drug) $401.36
- UBRELVY (Drug) $346.85
- NEXLETOL (Drug) $293.19
- NURTEC ODT (Drug) $276.90
- JARDIANCE (Drug) $232.07
- Ozempic (Drug) $209.61
- FARXIGA (Drug) $207.39
- ELIQUIS (Drug) $205.91
- AIRSUPRA (Drug) $203.80
- REXULTI (Drug) $179.25
- NOCDURNA (Drug) $133.30
- XIFAXAN (Drug) $123.20
- FREESTYLE LIBRE 2 (Device) $122.02
- RYBELSUS (Drug) $116.34
- TOUJEO (Biological) $114.48
- BELSOMRA (Drug) $114.28
- OFEV (Drug) $107.47
- Kerendia (Drug) $100.01
- SOLIQUA 100/33 (Biological) $97.59
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Lexington
Alisha Clemons, Aprn, APRN
Family — Payments: $38,192
Rose Pierson, Arnp, ARNP
Family — Payments: $12,246
Lauren Maupin, Arnp, Fnp-C, ARNP, FNP-C
Family — Payments: $11,985
Laura Travis, Aprn, APRN
Family — Payments: $10,435
Michael Thorarinson, Fnp-Bc, FNP-BC
Family — Payments: $10,409
Rhiannon Black, Aprn, APRN
Family — Payments: $9,756